Lu-yi Huang
Key Laboratory Of Molecular Biology For Diseases
Chongqing, 400016, China
Chongqing, 400016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Destabilization of lipoma-preferred partner by TGF-β-induced O-GlcNAcylation promotes hepatocellular carcinoma metastasis.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: October 23, 2025
Glucosamine suppresses hepatocellular carcinoma progression through dual inhibition of cell cycle progression and nucleotide metabolism.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: July 20, 2025
GFAT1 promotes the progression of hepatocellular carcinoma via enhancing the O-GlcNAcylation of VEZF1.
Journal: Cell death & disease
Published: November 28, 2024
High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate.
Journal: Cell metabolism
Published: March 14, 2023
O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma.
Journal: Oncogene
Published: September 10, 2022
Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products.
Journal: Signal transduction and targeted therapy
Published: December 16, 2020
Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 08, 2020
A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
Journal: The Journal of infectious diseases
Published: February 23, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026